STOCK TITAN

Molina Healthcare (MOH) director receives 170-share stock grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

SOISTMAN FRANCIS S JR reported acquisition or exercise transactions in this Form 4 filing.

Molina Healthcare, Inc. director Francis S. Soistman Jr. received a grant of 170 shares of common stock on May 6, 2026 under the company’s 2025 Incentive Plan, as a prorated quarterly director award. The grant was valued at the closing price of $197.44 per share on that date, and following this award he directly holds 670 shares of Molina Healthcare common stock.

Positive

  • None.

Negative

  • None.
Insider SOISTMAN FRANCIS S JR
Role null
Type Security Shares Price Value
Grant/Award Common Stock 170 $197.44 $34K
Holdings After Transaction: Common Stock — 670 shares (Direct, null)
Footnotes (1)
  1. Grant of stock under the Issuer's 2025 Incentive Plan in connection with the Reporting Person's services as a Director. Represents the prorated quarterly director grant. Mr. Soistman was elected as a director on May 6, 2026. Represents the closing price of the Issuer's common stock on May 6, 2026.
Shares granted 170 shares Director stock grant on May 6, 2026
Grant price per share $197.44 per share Closing price on May 6, 2026
Shares held after grant 670 shares Total direct holdings following transaction
2025 Incentive Plan financial
"Grant of stock under the Issuer's 2025 Incentive Plan in connection with the Reporting Person's services as a Director."
prorated quarterly director grant financial
"Represents the prorated quarterly director grant."
Common Stock financial
"security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SOISTMAN FRANCIS S JR

(Last)(First)(Middle)
200 OCEANGATE
SUITE 100

(Street)
LONG BEACH CALIFORNIA 90802

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/06/2026A(1)170(2)A$197.44(3)670D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Grant of stock under the Issuer's 2025 Incentive Plan in connection with the Reporting Person's services as a Director.
2. Represents the prorated quarterly director grant. Mr. Soistman was elected as a director on May 6, 2026.
3. Represents the closing price of the Issuer's common stock on May 6, 2026.
Remarks:
Jeff D. Barlow, power of attorney for Francis Soistman05/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Molina Healthcare (MOH) report for Francis S. Soistman Jr.?

Molina Healthcare reported that director Francis S. Soistman Jr. received a grant of 170 shares of common stock. The award was issued under the 2025 Incentive Plan as compensation for his director services, reflecting a prorated quarterly director grant upon his election.

On what date did Francis S. Soistman Jr. receive his Molina Healthcare (MOH) stock grant?

Francis S. Soistman Jr. received the stock grant on May 6, 2026. This date aligns with his election as a director, and the grant represents a prorated quarterly director award under Molina Healthcare’s 2025 Incentive Plan for board service compensation.

How many Molina Healthcare (MOH) shares were granted to Francis S. Soistman Jr. and at what price?

He was granted 170 shares of Molina Healthcare common stock at a value of $197.44 per share. That price represents the closing market price of the company’s common stock on May 6, 2026, the date of his director election and grant.

What is Francis S. Soistman Jr.’s Molina Healthcare (MOH) shareholding after this grant?

After the grant, Francis S. Soistman Jr. directly holds 670 shares of Molina Healthcare common stock. This total includes the newly awarded 170 shares received on May 6, 2026, as a prorated quarterly director grant under the 2025 Incentive Plan.

Was the Molina Healthcare (MOH) transaction for Francis S. Soistman Jr. a market purchase or a compensation grant?

The transaction was a compensation-related stock grant, not a market purchase. It is classified as a grant or award acquisition under the 2025 Incentive Plan, issued in connection with his services as a director and his election on May 6, 2026.